Cline Scientific: The new issue closes on July 12
Cline Scientific AB's Rights Issue closes tomorrow, July 12. The rights issue gives existing shareholders the right to subscribe for two new shares for each share owned for SEK 0.24 per share. If it is fully subscribed, the issue can add approximately SEK 9.25 million before issue costs, which are calculated at SEK 0.6 million. The minimum limit for completing the issue is set at SEK 5.5 million, which means that if the issue is not subscribed to this level, the issue will not be carried out.The money raised in the issue will primarily be used for our stem cell therapy project StemCART.